We used established neuroblastoma cell lines with high, low, or heterogeneous antigen expression, and showed that the in vitro efficacy of L1CAM-directed CAR T cells was significantly reduced when the tumor antigen was less strongly or heterogeneously expressed on tumor cells. Here, L1CAM is linked to neuroblastoma.